1. Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer

   • Edith A. Perez

   Review 29 April 2008 Pages: 195 - 201

2. Programmed Cell Death 4 inhibits breast cancer cell invasion by increasing Tissue Inhibitor of Metalloproteinases-2 expression

   • René Nieves-Alicea
   • Nancy H. Colburn
   • Ana M. Tari

   Preclinical Study 04 April 2008 Pages: 203 - 209

   

3. Src inhibitors in early breast cancer: a methodology, feasibility and variability study

   • R. J. Jones
   • O. Young
   • J. M. Dixon

   Preclinical Study 14 April 2008 Pages: 211 - 221

   

4. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence

   • Ana Rita Marques
   • Elsa Teixeira
   • José Luís Passos-Coelho

   Preclinical Study 13 April 2008 Pages: 223 - 232

   

5. Transcriptional profiles of progestogen effects in the postmenopausal breast

   • Charles E. Wood
   • Thomas C. Register
   • J. Mark Cline

   Preclinical Study 11 April 2008 Pages: 233 - 242

   

6. The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology

   • Emad A. Rakha
   • Muhammad S. Gill
   • Ian O. Ellis

   Preclinical Study 11 April 2008 Pages: 243 - 250

   

7. RETRACTED ARTICLE: Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation

   • Ivan Stigliano
   • Lydia Puricelli
   • María Giselle Peters

   Preclinical Study 11 April 2008 Pages: 251 - 262

   

8. Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

   • Thomas Frogne
   • Rikke V. Benjaminsen
   • Anne E. Lykkesfeldt

   Preclinical study 14 April 2008 Pages: 263 - 275

   

9. Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells

   • Hua Zhang
   • Deepali Sachdev
   • Douglas Yee

   Preclinical Study 17 April 2008 Pages: 277 - 285

   

10. Molecular profiles of progesterone receptor loss in human breast tumors

    • Chad J. Creighton
    • C. Kent Osborne
    • Rachel Schiff

    Preclinical Study 19 April 2008 Pages: 287 - 299

    

11. Axillary recurrence after negative sentinel lymph node biopsy

    • Hee Jeong Kim
    • Byung Ho Son
    • Sei Hyun Ahn

    Clinical Trial 04 April 2008 Pages: 301 - 305

12. Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region

    • Gregory M. Richards
    • Wolfgang A. Tomé
    • Steven P. Howard

    Clinical Trial 04 April 2008 Pages: 307 - 313

    

13. Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence

    • Hetty E. Carraway
    • Shelun Wang
    • Julie R. Lange

    Clinical Trial 11 April 2008 Pages: 315 - 325

14. Association of genetic polymorphisms of ER-α and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women

    • Lina Zhang
    • Lin Gu
    • Kexin Chen

    Epidemiology 16 July 2008 Pages: 327 - 338

    

15. Breast cancer characteristics at diagnosis and survival among Arab–American women compared to European– and African–American women

    • Sharon Hensley Alford
    • Kendra Schwartz
    • Sofia D. Merajver

    Epidemiology 15 April 2008 Pages: 339 - 346

    

16. Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population

    • Indu Kohaar
    • Pratibha Tiwari
    • Mausumi Bharadwaj

    Epidemiology 14 April 2008 Pages: 347 - 355

17. Changes in quality of life among breast cancer patients three years post-diagnosis

    • Wei Lu
    • Yong Cui
    • Xiao-Ou Shu

    Epidemiology 14 April 2008 Pages: 357 - 369

    

18. HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis

    • Weiyang Tao
    • Chunyang Wang
    • Hongchi Jiang

    Epidemiology 26 April 2008 Pages: 371 - 376

    

19. Effect of Coenzyme Q₁₀, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles

    • Srinivasan Yuvaraj
    • Vummidi Gridhar Premkumar
    • Panchanatham Sachdanandam

    Brief Report 22 April 2008 Pages: 377 - 384

20. Poor usage of HUGO standard gene nomenclature in breast cancer studies

    • Marc Lacroix

    Letter to the Editor 10 April 2008 Pages: 385 - 386

21. Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?

    • Vuk Stambolic
    • James R. Woodgett
    • Pamela J. Goodwin

    Letter to the Editor 26 April 2008 Pages: 387 - 389

22. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model

    • Sirwan M. Hadad
    • Virginia Appleyard
    • Alastair M. Thompson

    Letter to the editor 18 April 2008 Pages: 391 - 391